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Abstract: A solitary fibrous tumor (SFT) is a benign neoplasm, firstly described as a mesenchymal 
tumor of the pleura. Its incidence range in the head and neck region is about 5–27%, but only rarely 
does it affect paranasal sinuses. The differential diagnosis is challenging, owing to its erosive growth 
pattern and immuno-histochemical features. SFTs have an aggressive behavior and an important 
recurrence potential. Therefore, a radical surgical excision is the gold standard therapeutic proce-
dure. A rare SFT originating from the right maxillary sinus is reported here. The 37-year-old patient 
presented to the outpatient clinic with a painful expansive lesion in the whole right maxillary re-
gion. The overlying skin was inflamed and the patient had no epistaxis episodes. The 1.5 dentary 
element tested negative for vitality; however, a puncture of the lesion led to a hematic spill and no 
purulent discharge. An endoscopic-guided biopsy was suggestive either of SFT or hemangioperic-
toma, excluding a malignant neoplasm. A multi-equipe surgical team was activated. The lesion was 
embolized in order to achieve a good hemostatic control and, after 48 h, the neoplasm was radically 
excised with a combined open and endoscopic approach. The patient was disease-free at 12-month 
radiological and clinical follow-up. Given the rarity of this lesion and the delicacy required in ad-
dressing head and neck neoplasms, we believe that the present case report might be of help in fur-
ther understanding how to approach cranio-facial SFTs. 




A solitary fibrous tumor (SFT) is a rare mesenchymal tumor, firstly described by 
Klemperer and Rabin in 1931 as a pleural neoplasm [1]. Nevertheless, it can derive from 
other serous membranes and in any anatomic site, with approximately 5–27% of SFTs 
arising in the head and neck region [2,3]. Within this anatomic region, it more frequently 
affects the oral cavity and the orbit, while its incidence in paranasal sinuses and nasal 
cavities is very rare [4,5]. 
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Given its rarity and the paucity of pathognomonic clinico-radiological features, the 
differential diagnosis of SFT can be very tricky. Moreover, only recently have SFTs’ main 
immunohistochemical characteristics been delineated [2,3]. 
We describe here an interesting case of SFT arising from the right maxillary sinus and 
involving the ipsilateral infratemporal fossa, nasal fossa, vestibular space, and even or-
bital floor. 
2. Case Presentation 
2.1. Clinical Presentation and Preoperative Imaging 
A thirty-seven-year-old woman presented at the outpatient clinic with an ingraves-
cent right nasal obstruction beginning 12 months previously and a right canine fossa 
swelling that appeared 4 months earlier. The patient was previously evaluated by the ear, 
nose, and throat (ENT) service and underwent a computed tomography scan (CT) of the 
paranasal sinuses, without contrast enhancement (Figure 1a,b). 
 
Figure 1. Preoperative imaging. (a) CT, axial view; (b) CT, coronal view; (c) MRI, sagittal view; (d) 
MRI, coronal view. 
The radiological exam showed an expansive hypodense lesion occupying the whole 
right maxillary sinus, with bone erosion of the surrounding structures (right orbital floor, 
antero-lateral, posterior, and medial walls of the right maxillary sinus) and the upper right 
vestibular fornix, the right nasal fossa, and the right infratemporal fossa invasion. The 
mass was located periapically to the last right upper premolar and the first two upper 
molars. At the endoscopic evaluation, the mass was covered by intact respiratory mucosa 
and a complete obstruction of the right middle meatus and of the right osteo-meatal com-
plex was determined. Therefore, magnetic resonance imaging (MRI) with medium con-
trast and a maxillo-facial evaluation were prescribed. 
The MRI showed a neoformation of 50 × 49 × 44 mm in size, with regular margins. 
The mass was iso-intense compared with the muscle tissue in T1-weighted sequences, 
dishomogeneously hyper-intense in T2-weighted sequences, and showed a massive and 
irregular contrast enhancement (Figure 1c,d). 
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At the physical examination, the overlying skin appeared reddened and inflamed. 
The patient denied previous epistaxis episodes and denied dysesthesia of the right infra-
orbital nerve, while she referred to hypoesthesia of the ipsilateral hemipalate. The patient 
denied tobacco and alcohol use. Cold testing tooth vitality of the last right upper premolar 
proved no response. The puncture of the swelling on the vestibular side determined a 
hematic spill and no purulent discharge. An intraoral biopsy was performed, showing 
only respiratory mucosa with chronic phlogistic infiltration and without neoplastic ele-
ments; the histopathological examination result had no diagnostic value. Shortly after the 
bioptic procedure, the patient referred to the onset of a right infraorbital nerve paresthesia. 
Therefore, an endoscopic biopsy under general anesthesia was scheduled. During the sur-
gical intervention, a profuse hemorrhage from the mass bulging in the right nasal fossa 
occurred, which was controlled with bipolar cautery and right nasal cavity packing (Fig-
ure 2). 
 
Figure 2. Picture following the endoscopic bioptic procedure. A profuse bleeding occurred, con-
trolled with bipolar cautery and right nasal cavity packing. The bulging of the right cheek because 
of the mass is clearly evident. 
2.2. Incisional Biopsy Findings 
The new histopathological result showed monomorphic spindle cells combined with 
vascular elements. At the immunohistochemical evaluation, the cells intensively ex-
pressed bcl2 and had a weak, but wide CD34 expression. There was no smooth muscle 
actin (SMA), S-100 protein, and MNF-116 cytokeratin expression (Figure 3). 




Figure 3. Microscopically, the tumor was composed of monomorphic spindle cells arranged in fas-
cicles, with a vascular component showing a peculiar “hemangiopericytomatous” pattern. Spindle 
cells featured strong immunostaining for Bcl-2, and faint staining for CD34, whereas smooth muscle 
actin, S-100 protein, and cytokeratins were negative. (a,b) The nodule was composed of spindle cells 
arranged in fascicles; vessels with hemangiopericytomatous pattern were visible (H&E staining: 40× 
magnification (a); 100× magnification (b); 40× magnification (c) the only positive surgical margin is 
the one inside the maxillary sinus, which is not in contact with any other tissue. Spindle cells were 
positive for (d) STAT6: 100× magnification, (e) Bcl-2: 100× magnification , and (f) CD34: 100× mag-
nification. 
The cytoproliferative activity (evaluated with Mib-1 expression) was lower than 10%. 
The described characteristics suggested a mesenchymal tumor diagnosis and did not 
show any signs of malignancy. 
2.3. Intraoperative Imaging and Embolization Procedure 
Given the important vascular component of the lesion, a preoperative head and neck 
angiography was performed. The exam showed a mild contrast enhancement in the late 
arterial phase and progressively higher enhancement in capillary and venous phases. The 
mass was vascularized by the terminal branches of the ophthalmic artery, of the internal 
maxillary artery (especially the sphenopalatine artery), and of the facial artery (Figure 
4a,b). 




Figure 4. Angiographic imaging. (a,b) Pre-embolization images, showing the vascularization by ter-
minal branches of the ophthalmic artery, of the internal maxillary artery (especially the sphenopala-
tine artery), and of the facial artery; (c,d) images after the embolization of the internal maxillary and 
facial arteries, showing only the enhancement of the antero-superior compartment, supplied by the 
ophthalmic artery. 
Therefore, the vessels derived from the internal maxillary and facial arteries were 
embolized during the procedure. The subsequent angiography only showed the enhance-
ment of the antero-superior compartment (Figures 3d and 4c), supplied by the ophthalmic 
artery. No periprocedural complications were determined. 
2.4. Surgical Management 
Forty-eight hours after the angiographic procedure, the patient underwent the surgi-
cal excision of the neoformation throughout a combined endoscopic and transfacial ap-
proach. A Weber–Ferguson approach was carried out, with an intrasulcular incision of 
the right maxillary elements and a right tuber maxillae extension (Figure 5a,b).  




Figure 5. Intraoperative pictures. (a) Preoperative drawing; (b) isolation of the neoformation; (c) fine 
maxillary osteotomies performed with the piezosurgical scalpel; and (d) resection of the nasal part 
of the mass carried out with the harmonic scalpel. 
The antero-lateral wall of the right maxillary sinus appeared expanded and thinned, 
with infero-distal erosion. The right infraorbitary nerve was identified at the exit from the 
homonymous foramen and preserved. Osteotomies of the right naso-frontal pillar and of 
the right infero-lateral orbital frame were performed with a piezosurgical scalpel (Figure 
5c) (Piezosurgery®, Mectron Medical Technology, Carasco, Italy), without periosteal de-
tachment, consenting their upward flipping. This surgical maneuver allowed a wider 
view of the lesion. The intraoperative evaluation of the mass confirmed the right infratem-
poral fossa and right nasal fossa invasion, but showed no orbital floor erosion, which was 
only thinned. We used the harmonic scalpel (Harmonic Focus®+, Ethicon Endo-Surgery, 
Inc, Cincinnati, OH, USA) (Figure 5d) characterized by high-frequency mechanical energy 
to offer the surgeon controlled and precise incision and haemostasis. The mass appeared 
well capsulated and easily cleavable from circumstantial tissues. The tumor was then di-
rectly removed (Figure 6). 




Figure 6. Intraoperative pictures. (a,b) Resection of the neoformation; (c) post-resective site. (d) Mac-
roscopically, a 5.5 × 4 × 3 cm well-circumscribed nodule was visible. 
An endoscopic revision was performed, with excision of the residual neoplastic tis-
sues from right anterior and posterior ethmoidal structures and from the tail of the right 
inferior turbinate. The endoscopic evaluation excluded the invasion of the lamina cribrosa 
and of the right ethmoidal roof (Figure 7a,b). 
 
Figure 7. Intraoperative pictures. (a) Endoscopic image of the nasal fossa after the macroscopic re-
section (b) and at the end of the endoscopic one. (c) Titanium mesh reconstruction of the anterior 
maxillary sinus wall. 
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An accurate hemostasis control was performed. The right naso-frontal pillar and the 
right infero-lateral orbital frame were osteosynthetized back in their position with tita-
nium plate, while the anterior maxillary wall was reconstructed with a titanium mesh 
(Figure 7c). The transfacial approach was sutured and a right nasal packing was per-
formed. 
2.5. Solitary Fibrous Tumor Diagnosis 
Pathological examination of the surgical specimens revealed a 5.5 × 4 × 3 cm solitary, 
well-circumscribed, gray-brownish nodule (Figure 6d), confirming the pre-operative im-
munohistochemical diagnosis. 
Microscopically, the tumour was composed of monomorphic spindle cells arranged 
in fascicles, with a vascular component showing a peculiar “hemangiopericytomatous” 
pattern (Figure 3a,b). The only positive surgical margin is the one inside the maxillary 
sinus, which is not in contact with any other tissue (Figure 3c). 
Spindle cells featured strong immunostaining for STAT6 (Figure 3d) and Bcl-2 (Fig-
ure 1e), and faint staining for CD34 (Figure 3f), whereas smooth muscle actin, S-100 pro-
tein, and cytokeratins were negative. 
A diagnosis of solitary fibrous tumour was rendered. The surgical margins were clear 
from disease. 
2.6. Follow Up 
There were no postoperative complications. The patient did not refer to diplopia. The 
nasal packing was removed 48 h after the surgery, without subsequent epistaxis episodes. 
Immediate post-operative CT showed no macroscopic evidence of residual tumor and an 
appropriate bone reconstruction. The patient referred to transient infraorbital nerve hy-
poesthesia, which improved in three months. The 6-month post-operative CT excluded a 
relapse and sinusitis and confirmed the good reconstruction results obtained (Figure 8). 
  
Figure 8. Post-operative CT. (a) Axial view; (b) coronal view; and (c,d) sagittal views. 
Clinically, the patient showed good facial symmetry, without anesthetic and visible 
scars (Figure 9). 




Figure 9. Clinical pictures: (a) picture following the bioptic procedure with right nasal packing; (b) 
12 months post-operative picture. The bulging under the right cheek is not evident anymore. 
The patient referred to a complete disappearance of the right hemipalate hypoesthe-
sia, while a mild paresthesia of the right infraorbitary nerve was still present one year after 
the surgery. 
2.7. Patient Consent 
A written consent statement was provided by the patient to allow the publication of 
her case, including non-anonymized photos of her face during and after the surgical pro-
cedure. 
3. Discussion 
Without sex predilection, SFT generally occurs in the third to fourth decade of life 
[6]. This is consistent with our patient, a young 37-year-old woman. 
In the scientific literature, SFT is generally described as a slow-growing, painless, 
asymptomatic mass [4,5]. However, it also can determine progressive nasal obstruction, 
rhinorrhea, intermittent epistaxis, headache and anosmia, and even exophthalmos. On 
nasal endoscopy, SFT usually appears as a mass covered by an intact surface respiratory 
epithelium and/or metaplastic squamous mucosa. 
In the case described here, the patient referred only to a unilateral persistent nasal 
obstruction, and the nasoendoscopic exam showed an intact respiratory mucosa. While 
these features are consistent with those previously reported in literature, it has to be said 
that none of them are pathognomonic of SFT [3]. Therefore, the differential diagnosis must 
include glomangiopericytoma, inverted papilloma, hemangioma, leiomyomas, schwan-
noma, squamous cell carcinoma, juvenile angiofibroma, angiomatous polyps, nerve 
sheets tumors, mesenchymal chondrosarcoma, and byphenotipic synovial sarcoma [7–9]. 
The former definition of hemangiopericytoma has been integrated under the SFT nomen-
clature in the 2013 WHO classification [6]. Given the complexity of the clinical case, the 
treatment was given top priority even during the COVID-19 pandemic [10]. 
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The differential diagnosis between SFTs of the paranasal sinuses and the previously 
described tumors is very difficult on a clinical basis, given the non-specific clinical presen-
tation of them all. In fact, they can all manifest with nasal obstruction, recurrent epistaxis, 
sinusitis, and rhinorrhea [11–14]. 
In non-contrast to CT, SFT appears as a homogeneous mass and isodense with sur-
rounding tissue. Thinning and local remodeling of adjacent bone was observed, owing to 
a pressure effect (Figure 1). 
MRI findings included the following: well-circumscribed mass homogeneously iso-
intense on T1-weighted sequences, associated with heterogeneously marked enhance-
ment after gadolinium administration, and a possible hyperintensity on T2 image se-
quences [15,16], as described in the present case (Figure 1). Therefore, it is clear that SFT 
radiological findings are also not completely diriment [17]. 
Moreover, the radiological exams usually cannot be completely diriment regarding 
the final diagnosis, because of the similar aspects of SFTs and other mesenchymal tumors 
[18–22]. 
Given the great diversity of possible clinical pictures and the multiplicity of applica-
ble surgical strategies, the need to perform an incisional biopsy of the lesion is evident, in 
order to establish the diagnosis and the correct therapeutic procedure. 
Histopathologically, SFT consists of diffuse spindle cells within an attenuated colla-
genous stroma and a characteristic prominent vascular network. SFT cells also usually 
show low mitotic activity and the absence of nuclear pleomorphism [23]. 
At the immunochemical evaluation, SFT cells express CD34 and vimentin and mod-
erately express Bcl-2, while being negative for cytokeratin, S-100 protein, smooth muscle 
actin, and desmin [24]. CD34 positivity is not pathognomonic; nevertheless, the presence 
of CD34 and the contextual negativity of other reported markers can help to exclude a 
variety of soft tissue tumors, such as epithelial tumors, neurogenic tumors, and sarcomas 
[24]. Moreover, it has to be said that a typical rearrangement in chromosome 12q13, with 
a NAB2–STAT6 gene fusion, is present [25,26]. In our case, a STAT6 strong and diffuse 
nuclear expression pointed toward a diagnosis of SFT, with this marker being highly spe-
cific for this tumor. In fact, nuclear expression of STAT6 reflects the NAB2–STAT6 gene 
fusion that characterizes SFT [27]. Unfortunately, this molecular investigation could not 
be performed in our case, but it has to be said that only occasionally can other mesenchy-
mal tumors express STAT-6, both in cytoplasm and nucleus, rather than exclusively in the 
nucleus [28]. 
Glomangiopericytoma shows the same cellular component of SFT and the same pres-
ence of collagen areas. Moreover, it is positive for muscular markers (such as smooth mus-
cle actin) as well as leiomyomas. Nasopharingeal angiofibromas, on the other side, are 
usually positive for androgen receptor expression. None of the benign tumors mentioned 
here show CD34 and STAT6 expression [8]. Tumors with neural differentiation, such as 
neurofibroma or schwannoma, can histologically mimic SFTs, but they differ by express-
ing S-100 protein and SOX10 while lacking STAT6 expression [8]. Histologically, synovial 
sarcomas appear to be made of spindle cells, with the possible presence of collagen bands 
and branching vessels, similarly to SFTs. On the other side, they usually are more densely 
cellular and they lack of CD34 and STAT6 expressions, while being positive to keratin and 
EMA [28]. 
Even though there are not definite treatment guidelines for head and neck localiza-
tion, resectability is the most important prognostic factor; the en bloc radical surgical ex-
cision is thus the treatment of choice [29]. However, surgical margins’ control is frequently 
difficult in the paranasal region, and an endoscopic approach can be an efficient tool to 
grant magnification for an accurate resection with limited morbidity. Of course, in the 
present case, the only positive surgical margin is the one inside the maxillary sinus, which 
is not in contact with any other tissue (Figure 3c). For this reason, the surgical margins can 
be considered clear from disease. 
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Nevertheless, in a highly vascularized lesion, neither a transfacial approach nor an 
exclusively endoscopic approach grant an excellent control of the surgical margins in the 
paranasal sinuses. SFTs have an aggressive behavior and an important recurrence poten-
tial. 
Owing to the highly vascular nature of SFT, a surgical intervention can often deter-
mine a consistent blood loss. In the present case report, severe bleeding was also encoun-
tered during the endoscopic bioptic procedure. Therefore, we decided to preventively 
perform a selective endovascular embolization to obtain improved control of the bleeding 
during the following resection procedure. This foresight allowed a dramatic reduction of 
the blood supply to the neoformation, only leaving the vascularization from some 
branches of the ophthalmic artery. Indeed, the definitive resection procedure did not de-
termine a major blood loss. 
In order to obtain radicality and increase surgical safety, we planned a multidiscipli-
nary approach, combining the transfacial Weber–Ferguson approach with the magnifica-
tion power of endoscopy for better control and radicalization. 
Given the delicacy of the osteotomies performed, the use of the piezosurgical scalpel 
(Piezosurgery®, Mectron Medical Technology, Carasco, Italy) was preferred owing to its 
better impact on bone healing dynamics [30,31]. 
Moreover, to obtain an effective hemostasis in the nasal fossa and less extensive tis-
sue damage to reminder nasal mucosa, the harmonic scalpel (Harmonic Focus®+, Ethicon 
Endo-Surgery, Inc, Cincinnati, OH, USA) was used [32]. 
SFTs are generally indolent, with a low recurrence rate. Many risk assessment meth-
ods have been developed, while a universal system has not been approved yet [33–35]. 
Regarding intrathoracic SFTs, some inflammatory markers have also been proven to be of 
prognostic importance, such as fibrinogen levels and the neutrophil-to-lymphocyte-ratio 
(NLR) [36]. 
Overall, the recurrence rate accounts to 10–25%, with the possibility of a late relapse 
occurring even 10 years after the surgical resection [37,38]. Despite the limited number of 
reported cases, head and neck SFTs seem to have good prognostic results after radical 
surgical excision alone. Generally, no adjuvant therapies are required and surgical resec-
tion is considered curative. 
4. Conclusions 
Owing to its rarity and its aspecific morphologic appearance, sinonasal SFT may be 
difficult to distinguish from other mesenchymal lesions that more commonly arise in this 
area. 
An accurate differential diagnosis is necessary in order to avoid confusion with more 
aggressive lesions, which are more frequent in the head and neck region and which re-
quire an extensive resection, possibly functionally and aesthetically disabling. 
Radical surgical resection is the treatment of choice for SFT. Hopefully preceded by 
embolization, a combined open and endoscopic approach, in the context of a multi-equipe 
surgical team, can be helpful for an accurate resection with better visibility and improved 
hemostasis. 
Author Contributions: Conceptualization, M.D.B. and S.N.; methodology, A.A.; validation, A.A., 
S.N., and M.D.B.; formal analysis, A.P.; investigation, L.C., S.V., A.M.C. and L.P.; data curation, A.P.; 
writing—original draft preparation, M.D.B. and A.A.; writing—review and editing, A.A.; visualiza-
tion, A.P.; supervision, A.A. All authors have read and agreed to the published version of the man-
uscript. Please turn to the CRediT taxonomy for the term explanation. Authorship must be limited 
to those who have contributed substantially to the work reported. 
Funding: This research received no external funding.  
Institutional Review Board Statement: Due to the retrospective nature of this study, it was granted 
an exemption by the Institutional Review Board of the University Hospital of Modena, Italy. All 
Reports 2021, 4, 33 12 of 13 
 
 
procedures performed involving the human participant were in accordance with the 1964 Helsinki 
Declaration and its later amendments or comparable ethical standards. 
Informed Consent Statement: A written consent statement was provided by the patient to allow 
the publication of her case, including non-anonymized photos of her face during and after the sur-
gical procedure. 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Klemperer, P.; Rabin, C.B. Primary Neoplasms of the pleura. A report of five cases. Am. J. Ind. Med. 1992, 22, 4–31, 
doi:10.1002/ajim.4700220103. 
2. Demicco, E.G.; Park, M.S.; Araujo, D.M.; Fox, P.S.; Bassett, R.L.; Pollock, R.E.; Lazar, A.J.; Wang, W.-L. Solitary fibrous tumor: 
A clinicopathological study of 110 cases and proposed risk assessment model. 2012, 25, 1298–1306, 
doi:10.1038/modpathol.2012.83. 
3. Gold, J.S.; Antonescu, C.R.; Hajdu, C.; Ferrone, C.R.; Hussain, M.; Lewis, J.J.; Brennan, M.F.; Coit, D.G. Clinicopathologic 
correlates of solitary fibrous tumors. Cancer 2002, 94, 1057–1068, doi:10.1002/cncr.10328. 
4. Smith, S.C.; Gooding, W.E.; Elkins, M.; Patel, R.M.; Harms, P.W.; McDaniel, A.S.; Palanisamy, N.; Uram-Tuculescu, C.; Balzer, 
B.B.; Lucas, D.R.; et al. Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic Study. Am. J. 
Surg. Pathol. 2017, 41, 1642–1656, doi:10.1097/PAS.0000000000000940. 
5. Bernardini, F.P.; de Conciliis, C.; Schneider, S.; Kersten, R.C.; Kulwin, D.R. Solitary fibrous tumor of the orbit: Is it rare? Report 
of a case series and review of the literature. Ophthalmology 2003, 110, 1442–1448, doi:10.1016/S0161-6420(03)00459-7. 
6. Fletcher, C.D.M.; World Health Organization. International Agency for Research on Cancer. In WHO Classification of Tumours of 
Soft Tissue and Bone; 2013; ISBN 9789283224341. 
7. Martin-Broto, J.; Mondaza-Hernandez, J.L.; Moura, D.S.; Hindi, N. A Comprehensive Review on Solitary Fibrous Tumor: New 
Insights for New Horizons. Cancers 2021, 13, 2913, doi:10.3390/cancers13122913. 
8. Tariq, M.U.; Din, N.U.; Abdul-Ghafar, J.; Park, Y.-K. The many faces of solitary fibrous tumor; diversity of histological features, 
differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior. 
Diagn. Pathol. 2021, 16, 32, doi:10.1186/s13000-021-01095-2. 
9. Thompson, L.D.R.; Lau, S.K. Sinonasal Tract Solitary Fibrous Tumor: A Clinicopathologic Study of Six Cases with a 
Comprehensive Review of the Literature. Head Neck Pathol. 2018, 12, 471–480, doi:10.1007/s12105-017-0878-y. 
10. Di Bartolomeo, M.; Pellacani, A.; Negrello, S.; Chiarini, L.; Anesi, A. Emerging challenges and possible strategies in maxillo-
facial and oral surgery during the COVID-19 pandemic. J. Oral Sci. 2020, 62, 452–454, doi:10.2334/josnusd.20-0235. 
11. Thobejane, O.; Maharaj, S. Nasal Septal Angiofibroma. Ear. Nose. Throat J. 2021, 1455613211026517, 
doi:10.1177/01455613211026517. 
12. Ghaloo, S.K.; Dhanani, R.; Pasha, H.A.; Wasif, M.; Fatima, S.; Ikram, M. Glomangiopericytoma: A rare tumour of sinonasal 
cavity. J. Pak. Med. Assoc. 2020, 70, 2469–2471, doi:10.47391/JPMA.948. 
13. Assiri, K.S.; Al-Ahmari, M.S.; Alshahrani, M.S.; Mastor, A.; Elhawary, R. Clinical and Pathological Features of Angiomatous 
Nasal Polyps: A Report of Four Cases and Review of Literature. Cureus 2020, 12, e7642, doi:10.7759/cureus.7642. 
14. Katre, M.I. Neurofibroma of Nasal Cavity and Nasopharynx. Adv. Case Stud. 2017, 1, doi:10.31031/AICS.2017.01.000503. 
15. Bowe, S.N.; Wakely, P.E.; Ozer, E. Head and neck solitary fibrous tumors: Diagnostic and therapeutic challenges. Laryngoscope 
2012, 122, 1748–1755, doi:10.1002/lary.23350. 
16. Ganly, I.; Patel, S.G.; Stambuk, H.E.; Coleman, M.; Ghossein, R.; Carlson, D.; Edgar, M.; Shah, J.P. Solitary fibrous tumors of the 
head and neck: A clinicopathologic and radiologic review. Arch. Otolaryngol. Head Neck Surg. 2006, 132, 517–525, 
doi:10.1001/archotol.132.5.517. 
17. Yang, B.T.; Song, Z.L.; Wang, Y.Z.; Dong, J.Y.; Wang, Z.C. Solitary fibrous tumor of the sinonasal cavity: CT and MR imaging 
findings. AJNR. Am. J. Neuroradiol. 2013, 34, 1248–1251, doi:10.3174/ajnr.A3485. 
18. Suroyo, I.; Budianto, T. The role of diagnostic and interventional radiology in juvenile nasopharyngeal angiofibroma: A case 
report and literature review. Radiol. Case Rep. 2020, 15, 812–815, doi:10.1016/j.radcr.2020.04.017. 
19. Wang, X.; Liu, Y.; Chen, Q.; Xian, J. Evaluation of multiparametric MRI differentiating sinonasal angiomatous polyp from 
malignant tumors. Neuroradiology 2019, 61, 891–896, doi:10.1007/s00234-019-02225-w. 
20. Lin, N.; Liu, X.; Zhang, F.; Pan, Y.; Qi, M.; Sha, Y. Sinonasal synovial sarcoma: Evaluation of the role of radiological and 
clinicopathological features in diagnosis. Clin. Radiol. 2021, 76, 78, doi:10.1016/j.crad.2020.08.007. 
21. Yang, B.T.; Wang, Z.C.; Xian, J.F.; Hao, D.P.; Chen, Q.H. Leiomyoma of the sinonasal cavity: CT and MRI findings. Clin. Radiol. 
2009, 64, 1203–1209, doi:10.1016/j.crad.2009.05.014. 
22. Suh, C.H.; Lee, J.H.; Lee, M.K.; Cho, S.J.; Chung, S.R.; Choi, Y.J.; Baek, J.H. CT and MRI Findings of Glomangiopericytoma in 
the Head and Neck: Case Series Study and Systematic Review. AJNR. Am. J. Neuroradiol. 2020, 41, 155–159, 
doi:10.3174/ajnr.A6336. 
Reports 2021, 4, 33 13 of 13 
 
 
23. Kao, Y.-C.; Lin, P.-C.; Yen, S.-L.; Huang, S.-C.; Tsai, J.-W.; Li, C.-F.; Tai, H.-C.; Lan, J.; Chuang, I.-C.; Yu, S.-C.; et al. 
Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous tumours: A comparative histological, 
immunohistochemical and molecular study of 36 cases. Histopathology 2016, 68, 492–501, doi:10.1111/his.12772. 
24. Han, Y.; Zhang, Q.; Yu, X.; Han, X.; Wang, H.; Xu, Y.; Qiu, X.; Jin, F. Immunohistochemical detection of STAT6, CD34, CD99 
and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas. Int. J. Clin. Exp. Pathol. 2015, 8, 13166–13175. 
25. Chmielecki, J.; Crago, A.M.; Rosenberg, M.; O’Connor, R.; Walker, S.R.; Ambrogio, L.; Auclair, D.; McKenna, A.; Heinrich, M.C.; 
Frank, D.A.; et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat. Genet. 
2013, 45, 131–132, doi:10.1038/ng.2522. 
26. Robinson, D.R.; Wu, Y.-M.; Kalyana-Sundaram, S.; Cao, X.; Lonigro, R.J.; Sung, Y.-S.; Chen, C.-L.; Zhang, L.; Wang, R.; Su, F.; et 
al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat. Genet. 2013, 
45, 180–185, doi:10.1038/ng.2509. 
27. Koelsche, C.; Schweizer, L.; Renner, M.; Warth, A.; Jones, D.T.W.; Sahm, F.; Reuss, D.E.; Capper, D.; Knösel, T.; Schulz, B.; et al. 
Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology 
2014, 65, 613–622, doi:10.1111/his.12431. 
28. Doyle, L.A.; Vivero, M.; Fletcher, C.D.; Mertens, F.; Hornick, J.L. Nuclear expression of STAT6 distinguishes solitary fibrous 
tumor from histologic mimics. Mod. Pathol. 2014, 27, 390–395, doi:10.1038/modpathol.2013.164. 
29. van Houdt, W.J.; Westerveld, C.M.A.; Vrijenhoek, J.E.P.; van Gorp, J.; van Coevorden, F.; Verhoef, C.; van Dalen, T. Prognosis 
of Solitary Fibrous Tumors: A Multicenter Study. Ann. Surg. Oncol. 2013, 20, 4090–4095, doi:10.1245/s10434-013-3242-9. 
30. Anesi, A.; Ferretti, M.; Cavani, F.; Salvatori, R.; Bianchi, M.; Russo, A.; Chiarini, L.; Palumbo, C. Structural and ultrastructural 
analyses of bone regeneration in rabbit cranial osteotomy: Piezosurgery versus traditional osteotomes. J. Cranio-Maxillofac. Surg. 
2018, 46, 107–118, doi:10.1016/j.jcms.2017.10.004. 
31. Anesi, A.; Di Bartolomeo, M.; Pellacani, A.; Ferretti, M.; Cavani, F.; Salvatori, R.; Nocini, R.; Palumbo, C.; Chiarini, L. Bone 
Healing Evaluation Following Different Osteotomic Techniques in Animal Models: A Suitable Method for Clinical Insights. 
Appl. Sci. 2020, 10, 7165, doi:10.3390/app10207165. 
32. Sherman, J.A.; Davies, H.T. Ultracision: The harmonic scalpel and its possible uses in maxillofacial surgery. Br. J. Oral Maxillofac. 
Surg. 2000, 38, 530–532, doi:10.1054/bjom.2000.0502. 
33. Lu, C.; Ji, Y.; Shan, F.; Guo, W.; Ding, J.; Ge, D. Solitary fibrous tumor of the pleura: An analysis of 13 cases. World J. Surg. 2008, 
32, 1663–1668, doi:10.1007/s00268-008-9604-y. 
34. Gholami, S.; Cassidy, M.R.; Kirane, A.; Kuk, D.; Zanchelli, B.; Antonescu, C.R.; Singer, S.; Brennan, M. Size and Location are the 
Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors. Ann. Surg. Oncol. 2017, 24, 3865–3871, 
doi:10.1245/s10434-017-6092-z. 
35. Demicco, E.G.; Wagner, M.J.; Maki, R.G.; Gupta, V.; Iofin, I.; Lazar, A.J.; Wang, W.-L. Risk assessment in solitary fibrous tumors: 
Validation and refinement of a risk stratification model. Mod. Pathol. 2017, 30, 1433–1442, doi:10.1038/modpathol.2017.54. 
36. Ghanim, B.; Hess, S.; Bertoglio, P.; Celik, A.; Bas, A.; Oberndorfer, F.; Melfi, F.; Mussi, A.; Klepetko, W.; Pirker, C.; et al. 
Intrathoracic solitary fibrous tumor—An international multicenter study on clinical outcome and novel circulating biomarkers. 
Sci. Rep. 2017, 7, 12557, doi:10.1038/s41598-017-12914-2. 
37. Baldi, G.G.; Stacchiotti, S.; Mauro, V.; Dei Tos, A.P.; Gronchi, A.; Pastorino, U.; Duranti, L.; Provenzano, S.; Marrari, A.; Libertini, 
M.; et al. Solitary fibrous tumor of all sites: Outcome of late recurrences in 14 patients. Clin. Sarcoma Res. 2013, 3, 4, 
doi:10.1186/2045-3329-3-4. 
38. Park, C.K.; Lee, D.H.; Park, J.Y.; Park, S.H.; Kwon, K.Y. Multiple recurrent malignant solitary fibrous tumors: Long-term follow-
up of 24 years. Ann. Thorac. Surg. 2011, 91, 1285–1288, doi:10.1016/j.athoracsur.2010.08.074. 
